|
MDC1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
2.87547763377916E-14 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62436730732907E-12 |
| Stage1-vs-Stage2 |
2.968000E-01 |
| Stage1-vs-Stage3 |
2.095800E-01 |
| Stage1-vs-Stage4 |
2.441600E-01 |
| Stage2-vs-Stage3 |
8.344300E-02 |
| Stage2-vs-Stage4 |
7.565600E-02 |
| Stage3-vs-Stage4 |
8.657200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
3.74000053149359E-10 |
| Normal-vs-Asian |
1.62436730732907E-12 |
| Caucasian-vs-AfricanAmerican |
3.076600E-01 |
| Caucasian-vs-Asian |
5.792400E-01 |
| AfricanAmerican-vs-Asian |
5.065600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
9.684600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
<1E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(81-100Yrs) |
6.11699999999438E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.205200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.551800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.135000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.277400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.457000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.071800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.988400000001E-05 |
| Classical-VS-Follicular |
2.055000E-01 |
| Classical-VS-Other |
1.812990E-01 |
| Classical-VS-Normal |
1.11022302462516E-16 |
| Tall-VS-Follicular |
3.037700E-02 |
| Tall-VS-Other |
6.899600E-01 |
| Tall-VS-Normal |
1.62447832963153E-12 |
| Follicular-VS-Other |
5.508200E-01 |
| Follicular-VS-Normal |
1.62436730732907E-12 |
| Other-VS-Normal |
7.60890000006675E-07 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
1.678950E-01 |
|
|
